22hon MSN
Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts
Q1 2026 Management View Dr. David Hung said the launch is being driven by steady demand and an improving mix toward earlier-line use: “We successfully treated approximately 200 new patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results